Abstract: ABSTRACT The present invention relates to polymorphic forms of Bictegravir potassium of Formula II, process for their preparation and pharmaceutical composition comprising it.
Not Submitted.
| # | Name | Date |
|---|---|---|
| 1 | 202141017972-Form2 Title Page_Provisiona_19-04-2021.pdf | 2021-04-19 |
| 2 | 202141017972-Form1_As Filed_19-04-2021.pdf | 2021-04-19 |
| 3 | 202141017972-Correspondence_As Filed_19-04-2021.pdf | 2021-04-19 |
| 4 | 202141017972-Form-5_After Provisional_04-05-2022.pdf | 2022-05-04 |
| 5 | 202141017972-Form-3_After Provisional_04-05-2022.pdf | 2022-05-04 |
| 6 | 202141017972-Form 2(Title Page)_Complete_04-05-2022.pdf | 2022-05-04 |
| 7 | 202141017972-Drawing_After Provisional_04-05-2022.pdf | 2022-05-04 |
| 8 | 202141017972-Description(Complete)_As Filed_04-05-2022.pdf | 2022-05-04 |
| 9 | 202141017972-Correspondence_After Provisional_04-05-2022.pdf | 2022-05-04 |
| 10 | 202141017972-Claims_After Provisional_04-05-2022.pdf | 2022-05-04 |
| 11 | 202141017972-Abstract_After Provisional_04-05-2022.pdf | 2022-05-04 |
| 12 | 202141017972-Correspondence_Priority Document_25-05-2022.pdf | 2022-05-25 |
| 13 | 202141017972-Request For Certified Copy_15-07-2022.pdf | 2022-07-15 |
| 14 | 202141017972-Form 2(Title Page)_Request for Certified Copy_16-08-2022.pdf | 2022-08-16 |
| 15 | 202141017972-Correspondence_Request for Certified Copy_16-08-2022.pdf | 2022-08-16 |
| 16 | 202141017972-Power of Attorney_Request for Certified Copy_16-0-8-2022.pdf | 2022-08-19 |
| 17 | 202141017972-Correspondence-101023.pdf | 2023-10-19 |
| 18 | 202141017972-Form 3-021123.pdf | 2023-11-06 |
| 19 | 202141017972-Correspondence-021123.pdf | 2023-11-06 |
| 20 | 202141017972-FORM 18 [05-04-2025(online)].pdf | 2025-04-05 |